286 related articles for article (PubMed ID: 10502325)
1. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B
Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
3. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
Debelenko LV; Zhuang Z; Emmert-Buck MR; Chandrasekharappa SC; Manickam P; Guru SC; Marx SJ; Skarulis MC; Spiegel AM; Collins FS; Jensen RT; Liotta LA; Lubensky IA
Cancer Res; 1997 Jun; 57(11):2238-43. PubMed ID: 9187127
[TBL] [Abstract][Full Text] [Related]
4. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
5. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas.
Hessman O; Lindberg D; Skogseid B; Carling T; Hellman P; Rastad J; Akerström G; Westin G
Cancer Res; 1998 Feb; 58(3):377-9. PubMed ID: 9458074
[TBL] [Abstract][Full Text] [Related]
6. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients.
Lubensky IA; Debelenko LV; Zhuang Z; Emmert-Buck MR; Dong Q; Chandrasekharappa S; Guru SC; Manickam P; Olufemi SE; Marx SJ; Spiegel AM; Collins FS; Liotta LA
Cancer Res; 1996 Nov; 56(22):5272-8. PubMed ID: 8912868
[TBL] [Abstract][Full Text] [Related]
7. [Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance].
Jiang WJ; Liu TH; Chen J; Gao J; Wu SF; Chen YJ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1705-9. PubMed ID: 15569430
[TBL] [Abstract][Full Text] [Related]
8. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
9. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.
Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N
Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646
[TBL] [Abstract][Full Text] [Related]
10. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
Guo SS; Wu AY; Sawicki MP
World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
[TBL] [Abstract][Full Text] [Related]
12. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.
Emmert-Buck MR; Lubensky IA; Dong Q; Manickam P; Guru SC; Kester MB; Olufemi SE; Agarwal S; Burns AL; Spiegel AM; Collins FS; Marx SJ; Zhuang Z; Liotta LA; Chandrasekharappa SC; Debelenko LV
Cancer Res; 1997 May; 57(10):1855-8. PubMed ID: 9157974
[TBL] [Abstract][Full Text] [Related]
13. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
14. Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors.
Ebrahimi SA; Wang EH; Wu A; Schreck RR; Passaro E; Sawicki MP
Cancer Res; 1999 Jan; 59(2):311-5. PubMed ID: 9927038
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
Pourani J; Kaserer K; Pfragner R
Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
[TBL] [Abstract][Full Text] [Related]
16. Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.
Hessman O; Skogseid B; Westin G; Akerström G
J Clin Endocrinol Metab; 2001 Mar; 86(3):1355-61. PubMed ID: 11238532
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic endocrine tumors with loss of heterozygosity at the multiple endocrine neoplasia type I locus.
Eubanks PJ; Sawicki MP; Samara GJ; Wan YJ; Gatti RA; Hurwitz M; Passaro E
Am J Surg; 1997 Jun; 173(6):518-20. PubMed ID: 9207166
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
19. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer.
Waber PG; Lee NK; Nisen PD
Oncogene; 1996 Jan; 12(2):365-9. PubMed ID: 8570213
[TBL] [Abstract][Full Text] [Related]
20. The human HNP36 gene is localized to chromosome 11q13 and produces alternative transcripts that are not mutated in multiple endocrine neoplasia, type 1 (MEN I) syndrome.
Williams JB; Rexer B; Sirripurapu S; John S; Goldstein R; Phillips JA; Haley LL; Sait SN; Shows TB; Smith CM; Gerhard DS
Genomics; 1997 Jun; 42(2):325-30. PubMed ID: 9192854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]